Max Healthcare Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
1,365.00
1,063.00
738.00
-68.00
89.00
8.00
Adjustment
184.00
225.00
241.00
504.00
220.00
156.00
Changes In working Capital
-159.00
155.00
-130.00
-376.00
-46.00
-48.00
Cash Flow after changes in Working Capital
1,391.00
1,445.00
849.00
59.00
262.00
117.00
Cash Flow from Operating Activities
1,121.00
1,284.00
740.00
117.00
249.00
88.00
Cash Flow from Investing Activities
-1,252.00
-102.00
-763.00
206.00
-126.00
-16.00
Cash Flow from Financing Activities
-263.00
-288.00
-294.00
191.00
144.00
-73.00
Net Cash Inflow / Outflow
-394.00
893.00
-317.00
515.00
267.00
-1.00
Opening Cash & Cash Equivalents
1,374.00
480.00
626.00
111.00
7.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
979.00
1,374.00
309.00
626.00
274.00
7.00
Compare Cash Flow Results of Max Healthcare
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
1365.32
935
430.00
46.02%
Adjustment
184.85
1644.7
-1,460.00
-88.76%
Changes In working Capital
-159.09
-192.8
33.00
17.48%
Cash Flow after changes in Working Capital
1391.08
2386.9
-995.00
-41.72%
Cash Flow from Operating Activities
1121.8
1920.2
-799.00
-41.58%
Cash Flow from Investing Activities
-1252.55
-1537.1
285.00
18.51%
Cash Flow from Financing Activities
-263.74
-311
48.00
15.20%
Net Cash Inflow / Outflow
-394.49
72.1
-466.00
-647.14%
Opening Cash & Cash Equivalents
1374.33
433.4
941.00
217.10%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
979.84
505.5
474.00
93.84%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -12.64% vs 73.41% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
1,121.80
1,284.13
-12.64%